PL1644493T3 - Regulacja kinazy regulowanej w COPD (kinaza RC) - Google Patents
Regulacja kinazy regulowanej w COPD (kinaza RC)Info
- Publication number
- PL1644493T3 PL1644493T3 PL04739941T PL04739941T PL1644493T3 PL 1644493 T3 PL1644493 T3 PL 1644493T3 PL 04739941 T PL04739941 T PL 04739941T PL 04739941 T PL04739941 T PL 04739941T PL 1644493 T3 PL1644493 T3 PL 1644493T3
- Authority
- PL
- Poland
- Prior art keywords
- kinase
- regulation
- regulated
- copd
- reagents
- Prior art date
Links
- 108091000080 Phosphotransferase Proteins 0.000 title abstract 3
- 102000020233 phosphotransferase Human genes 0.000 title abstract 3
- 102000001253 Protein Kinase Human genes 0.000 title 1
- 108060006633 protein kinase Proteins 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 101000582767 Homo sapiens Regucalcin Proteins 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000005754 cellular signaling Effects 0.000 abstract 1
- 230000002950 deficient Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03014688 | 2003-06-27 | ||
| EP04004818 | 2004-03-02 | ||
| EP04739941A EP1644493B1 (en) | 2003-06-27 | 2004-06-16 | Regulation of a kinase, 'regulated in copd kinase' (rc kinase) |
| PCT/EP2004/006474 WO2005001083A1 (en) | 2003-06-27 | 2004-06-16 | Regulation of kinase, ´regulated in copd kinase´ (rc kinase) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1644493T3 true PL1644493T3 (pl) | 2010-11-30 |
Family
ID=33553805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04739941T PL1644493T3 (pl) | 2003-06-27 | 2004-06-16 | Regulacja kinazy regulowanej w COPD (kinaza RC) |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7829685B2 (pl) |
| EP (1) | EP1644493B1 (pl) |
| JP (2) | JP4895808B2 (pl) |
| AT (1) | ATE470706T1 (pl) |
| AU (1) | AU2004251181B2 (pl) |
| CA (1) | CA2530663A1 (pl) |
| DE (1) | DE602004027632D1 (pl) |
| DK (1) | DK1644493T3 (pl) |
| ES (1) | ES2347247T3 (pl) |
| PL (1) | PL1644493T3 (pl) |
| WO (1) | WO2005001083A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7829685B2 (en) | 2003-06-27 | 2010-11-09 | Axikin Pharmaceuticals, Inc. | Regulation of kinase, regulated in COPD kinase (RC kinase) |
| JP5574990B2 (ja) * | 2008-03-10 | 2014-08-20 | リニーゲン、インコーポレイテッド | Ｃｏｐｄバイオマーカーシグネチャー |
| TW201341367A (zh) | 2012-03-16 | 2013-10-16 | Axikin Pharmaceuticals Inc | ３，５－二胺基吡唑激酶抑制劑 |
| NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
| HUE049801T2 (hu) | 2014-12-23 | 2020-10-28 | Sma Therapeutics Inc | 3,5-diaminopirazol kináz inhibitorok |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ241311A (en) | 1991-01-17 | 1995-03-28 | Gen Hospital Corp | Rna sequence having trans-splicing activity, plant strains |
| ES2130177T3 (es) | 1991-08-10 | 1999-07-01 | Medical Res Council | Tratamiento de poblaciones de celulas. |
| JP3720353B2 (ja) | 1992-12-04 | 2005-11-24 | メディカル リサーチ カウンシル | 多価および多重特異性の結合タンパク質、それらの製造および使用 |
| US5705151A (en) | 1995-05-18 | 1998-01-06 | National Jewish Center For Immunology & Respiratory Medicine | Gene therapy for T cell regulation |
| EP1373517A2 (en) | 2000-10-20 | 2004-01-02 | Incyte Genomics, Inc. | Human kinases |
| US6582946B1 (en) * | 2001-03-12 | 2003-06-24 | Applera Corporation | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| WO2002090525A2 (en) * | 2001-05-07 | 2002-11-14 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| AU2002331162A1 (en) | 2001-08-20 | 2003-03-10 | Bayer Healthcare Ag | Human serine/threonine kinase |
| US7829685B2 (en) * | 2003-06-27 | 2010-11-09 | Axikin Pharmaceuticals, Inc. | Regulation of kinase, regulated in COPD kinase (RC kinase) |
-
2004
- 2004-06-16 US US10/561,570 patent/US7829685B2/en not_active Expired - Fee Related
- 2004-06-16 JP JP2006515949A patent/JP4895808B2/ja not_active Expired - Fee Related
- 2004-06-16 DK DK04739941.5T patent/DK1644493T3/da active
- 2004-06-16 AT AT04739941T patent/ATE470706T1/de not_active IP Right Cessation
- 2004-06-16 WO PCT/EP2004/006474 patent/WO2005001083A1/en not_active Ceased
- 2004-06-16 CA CA002530663A patent/CA2530663A1/en not_active Abandoned
- 2004-06-16 DE DE602004027632T patent/DE602004027632D1/de not_active Expired - Lifetime
- 2004-06-16 PL PL04739941T patent/PL1644493T3/pl unknown
- 2004-06-16 AU AU2004251181A patent/AU2004251181B2/en not_active Ceased
- 2004-06-16 ES ES04739941T patent/ES2347247T3/es not_active Expired - Lifetime
- 2004-06-16 EP EP04739941A patent/EP1644493B1/en not_active Expired - Lifetime
-
2011
- 2011-06-20 JP JP2011136040A patent/JP2011234724A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1644493B1 (en) | 2010-06-09 |
| EP1644493A1 (en) | 2006-04-12 |
| DK1644493T3 (da) | 2010-09-13 |
| JP2011234724A (ja) | 2011-11-24 |
| WO2005001083A1 (en) | 2005-01-06 |
| US20080261903A1 (en) | 2008-10-23 |
| ES2347247T3 (es) | 2010-10-27 |
| AU2004251181B2 (en) | 2009-10-01 |
| DE602004027632D1 (de) | 2010-07-22 |
| US7829685B2 (en) | 2010-11-09 |
| JP4895808B2 (ja) | 2012-03-14 |
| AU2004251181A1 (en) | 2005-01-06 |
| JP2007527209A (ja) | 2007-09-27 |
| ATE470706T1 (de) | 2010-06-15 |
| HK1095355A1 (en) | 2007-05-04 |
| CA2530663A1 (en) | 2005-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005112981A3 (en) | Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells | |
| NO20070189L (no) | Immunoglobuliner | |
| CA2530663A1 (en) | Regulation of kinase, 'regulated in copd kinase' (rc kinase) | |
| WO2002040673A3 (en) | Compositions and methods relating to lung specific genes and proteins | |
| WO2001090160A3 (en) | REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE | |
| EP1805510A4 (en) | THERAPEUTIC STRATEGY FOR THE TREATMENT OF AUTOIMMUNE AND DEGENERATIVE DISEASES | |
| WO2003033708A3 (en) | Regulation of human serine/threonine protein kinase | |
| WO2002033056A3 (en) | Regulation of human serine-threonine protein kinase | |
| WO2003033709A3 (en) | Regulation of human serine/threonine protein kinase | |
| WO2002033095A3 (en) | Regulation of human serine-threonine protein kinase | |
| WO2002053749A3 (en) | Regulation of human serine-threonine protein kinase | |
| TW200628488A (en) | Deglycosylated and desialidated long pentraxin PTX3 | |
| WO2002000853A3 (en) | Regulation of human caspase-1-like protease | |
| AU2002238523A1 (en) | Regulation of human wee1-like serine/threonine protein kinase | |
| WO2003020899A3 (en) | Compositions and methods relating to lung specific genes and proteins | |
| WO2004056866A8 (en) | Asthma susceptibility locus | |
| WO2002092798A3 (en) | Regulation of human phosphatidic acid phosphatase type 2c-like protein | |
| WO2003020897A3 (en) | Compositions and methods relating to ovary specific genes and proteins | |
| WO2002036755A3 (en) | Regulation of human inositolpolyphosphate 5-phosphatase | |
| WO2002081705A3 (en) | Regulation of human gnat acetyltransferase-like protein | |
| WO2002097073A3 (en) | Regulation of human phospholipase c delta-like enzyme | |
| WO2002034920A3 (en) | Regulation of human ceruloplasmin-like protein | |
| Gowda et al. | CK2 Inhibitor CX4945 Shows Strong In Vivo Anti Leukemia Effect in AML Via Augmented Ikaros-Mediated Regulation of Global Epigenetic Landscape | |
| WO2002042460A3 (en) | Compositions and methods relating to colon specific genes and proteins | |
| WO2002081706A3 (en) | Regulation of human phosphatase-like protein |